Process View
The process whose specific outcome is the progression of the female gonad over time, from its formation to the mature structure.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "female gonad development"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| BCL2 | B-cell CLL/lymphoma 2 | 0.951 | Mouse Rat | |
| INSR | insulin receptor | 0.941 | Fly | |
| ESR1 | estrogen receptor 1 | 0.761 | Mouse | |
| EGFR | epidermal growth factor receptor | 0.742 | ||
| TP53 | tumor protein p53 | 0.626 | ||
| NRP1 | neuropilin 1 | 0.541 | ||
| POU5F1 | POU class 5 homeobox 1 | 0.540 | ||
| BCL2L1 | BCL2-like 1 | 0.381 | Mouse Rat | |
| VEGFA | vascular endothelial growth factor A | 0.374 | Mouse | |
| GRB10 | growth factor receptor-bound protein 10 | 0.321 | ||
| BCAR1 | breast cancer anti-estrogen resistance 1 | 0.305 | ||
| PTPN1 | protein tyrosine phosphatase, non-receptor type 1 | 0.291 | ||
| IRS1 | insulin receptor substrate 1 | 0.289 | ||
| HNRNPD | heterogeneous nuclear ribonucleoprotein D (AU-rich element RNA binding protein 1, 37kDa) | 0.249 | ||
| FLT1 | fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) | 0.246 | ||
| TEK | TEK tyrosine kinase, endothelial | 0.230 | ||
| PTPN13 | protein tyrosine phosphatase, non-receptor type 13 (APO-1/CD95 (Fas)-associated phosphatase) | 0.216 | ||
| AP1M1 | adaptor-related protein complex 1, mu 1 subunit | 0.207 | ||
| PDGFRA | platelet-derived growth factor receptor, alpha polypeptide | 0.171 | Mouse | |
| PDX1 | pancreatic and duodenal homeobox 1 | 0.147 | ||
| HNRPDL | heterogeneous nuclear ribonucleoprotein D-like | 0.143 | ||
| CDK2 | cyclin-dependent kinase 2 | 0.128 | ||
| PLAU | plasminogen activator, urokinase | 0.117 | ||
| HNRNPK | heterogeneous nuclear ribonucleoprotein K | 0.103 | ||
| TDGF1 | teratocarcinoma-derived growth factor 1 | 0.097 | ||
| HNRNPU | heterogeneous nuclear ribonucleoprotein U (scaffold attachment factor A) | 0.096 | ||
| DDX5 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 5 | 0.090 | ||
| MDM2 | Mdm2 p53 binding protein homolog (mouse) | 0.074 | ||
| CASP8 | caspase 8, apoptosis-related cysteine peptidase | 0.074 | ||
| ZNF512B | zinc finger protein 512B | 0.073 | ||
| IRS2 | insulin receptor substrate 2 | 0.071 | ||
| FSTL1 | follistatin-like 1 | 0.068 | ||
| NCOR2 | nuclear receptor corepressor 2 | 0.066 | ||
| EIF2B4 | eukaryotic translation initiation factor 2B, subunit 4 delta, 67kDa | 0.065 | ||
| TGFBR2 | transforming growth factor, beta receptor II (70/80kDa) | 0.065 | ||
| CRKL | v-crk sarcoma virus CT10 oncogene homolog (avian)-like | 0.063 | ||
| JAK2 | Janus kinase 2 | 0.063 | ||
| NF2 | neurofibromin 2 (merlin) | 0.061 | ||
| MPDZ | multiple PDZ domain protein | 0.061 | ||
| BAK1 | BCL2-antagonist/killer 1 | 0.055 | ||
| TGFB1 | transforming growth factor, beta 1 | 0.053 | ||
| HNRNPH3 | heterogeneous nuclear ribonucleoprotein H3 (2H9) | 0.053 | ||
| NCOA2 | nuclear receptor coactivator 2 | 0.052 | ||
| STAT5A | signal transducer and activator of transcription 5A | 0.051 | Mouse | |
| KDR | kinase insert domain receptor (a type III receptor tyrosine kinase) | 0.049 | Mouse | |
| SHC2 | SHC (Src homology 2 domain containing) transforming protein 2 | 0.049 | ||
| ABL1 | c-abl oncogene 1, non-receptor tyrosine kinase | 0.047 | ||
| PSMD4 | proteasome (prosome, macropain) 26S subunit, non-ATPase, 4 | 0.043 | ||
| TIMP2 | TIMP metallopeptidase inhibitor 2 | 0.042 | ||
| E2F1 | E2F transcription factor 1 | 0.042 | ||
| CRADD | CASP2 and RIPK1 domain containing adaptor with death domain | 0.040 | ||
| PRKCA | protein kinase C, alpha | 0.040 | Fly | |
| CASP10 | caspase 10, apoptosis-related cysteine peptidase | 0.039 | ||
| PCGF2 | polycomb group ring finger 2 | 0.037 | ||
| CPE | carboxypeptidase E | 0.036 | ||
| FANCE | Fanconi anemia, complementation group E | 0.036 | ||
| AKT1 | v-akt murine thymoma viral oncogene homolog 1 | 0.035 | ||
| IGF1R | insulin-like growth factor 1 receptor | 0.035 | Fly | |
| FANCD2 | Fanconi anemia, complementation group D2 | 0.035 | ||
| TMSB4X | thymosin beta 4, X-linked | 0.033 | ||
| RNR2 | l-rRNA | 0.033 | ||
| CSNK1D | casein kinase 1, delta | 0.032 | ||
| HDAC6 | histone deacetylase 6 | 0.031 | ||
| AR | androgen receptor | 0.030 | ||
| BRCA2 | breast cancer 2, early onset | 0.029 | Mouse | |
| GAB1 | GRB2-associated binding protein 1 | 0.029 | ||
| HIF1A | hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 0.028 | ||
| CBL | Cas-Br-M (murine) ecotropic retroviral transforming sequence | 0.028 | ||
| FANCC | Fanconi anemia, complementation group C | 0.028 | ||
| NEUROD1 | neurogenic differentiation 1 | 0.027 | ||
| EIF2B5 | eukaryotic translation initiation factor 2B, subunit 5 epsilon, 82kDa | 0.027 | ||
| FOXO1 | forkhead box O1 | 0.027 | ||
| MYLK2 | myosin light chain kinase 2 | 0.026 | ||
| ARNT | aryl hydrocarbon receptor nuclear translocator | 0.026 | ||
| FASLG | Fas ligand (TNF superfamily, member 6) | 0.025 | ||
| RNF144B | ring finger protein 144B | 0.024 | ||
| NCF1 | neutrophil cytosolic factor 1 | 0.024 | ||
| VEGFC | vascular endothelial growth factor C | 0.022 | ||
| NCOA1 | nuclear receptor coactivator 1 | 0.022 | ||
| PGF | placental growth factor | 0.022 | ||
| BMP2 | bone morphogenetic protein 2 | 0.021 | ||
| BID | BH3 interacting domain death agonist | 0.021 | ||
| GDF5 | growth differentiation factor 5 | 0.021 | ||
| UHRF2 | ubiquitin-like with PHD and ring finger domains 2 | 0.021 | ||
| RBMX | RNA binding motif protein, X-linked | 0.021 | ||
| EP300 | E1A binding protein p300 | 0.021 | ||
| PPP5C | protein phosphatase 5, catalytic subunit | 0.021 | ||
| MYC | v-myc myelocytomatosis viral oncogene homolog (avian) | 0.020 | ||
| GIT1 | G protein-coupled receptor kinase interacting ArfGAP 1 | 0.020 | ||
| RBPMS | RNA binding protein with multiple splicing | 0.019 | ||
| SP1 | Sp1 transcription factor | 0.019 | ||
| DAXX | death-domain associated protein | 0.019 | ||
| ACTB | actin, beta | 0.018 | ||
| HNRNPL | heterogeneous nuclear ribonucleoprotein L | 0.018 | ||
| EIF2B2 | eukaryotic translation initiation factor 2B, subunit 2 beta, 39kDa | 0.018 | ||
| HES1 | hairy and enhancer of split 1, (Drosophila) | 0.018 | ||
| WT1 | Wilms tumor 1 | 0.017 | Mouse | |
| BCL2L11 | BCL2-like 11 (apoptosis facilitator) | 0.016 | ||
| IGSF21 | immunoglobin superfamily, member 21 | 0.016 | ||
| RPS6KA6 | ribosomal protein S6 kinase, 90kDa, polypeptide 6 | 0.016 | ||
| JDP2 | Jun dimerization protein 2 | 0.015 | ||
| FADD | Fas (TNFRSF6)-associated via death domain | 0.015 | ||
| NCOA6 | nuclear receptor coactivator 6 | 0.015 | ||
| PSMC5 | proteasome (prosome, macropain) 26S subunit, ATPase, 5 | 0.015 | ||
| INHBA | inhibin, beta A | 0.015 | ||
| PLAT | plasminogen activator, tissue | 0.015 | ||
| TLE1 | transducin-like enhancer of split 1 (E(sp1) homolog, Drosophila) | 0.015 | ||
| FGFR2 | fibroblast growth factor receptor 2 | 0.015 | ||
| CDH5 | cadherin 5, type 2 (vascular endothelium) | 0.015 | ||
| THBS2 | thrombospondin 2 | 0.015 | ||
| PPARA | peroxisome proliferator-activated receptor alpha | 0.014 | ||
| RAD23B | RAD23 homolog B (S. cerevisiae) | 0.014 | ||
| SYCP3 | synaptonemal complex protein 3 | 0.014 | ||
| A2M | alpha-2-macroglobulin | 0.014 | ||
| ERBB2 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) | 0.014 | ||
| FGF10 | fibroblast growth factor 10 | 0.014 | ||
| TRRAP | transformation/transcription domain-associated protein | 0.014 | ||
| ESR2 | estrogen receptor 2 (ER beta) | 0.014 | Rat | |
| SFN | stratifin | 0.014 | ||
| LAT | linker for activation of T cells | 0.013 | ||
| CAV1 | caveolin 1, caveolae protein, 22kDa | 0.013 | ||
| PLCG1 | phospholipase C, gamma 1 | 0.013 | ||
| PDGFRB | platelet-derived growth factor receptor, beta polypeptide | 0.013 | ||
| DIP2A | DIP2 disco-interacting protein 2 homolog A (Drosophila) | 0.013 | ||
| TOP1 | topoisomerase (DNA) I | 0.012 | ||
| MAP3K5 | mitogen-activated protein kinase kinase kinase 5 | 0.012 | ||
| CCND1 | cyclin D1 | 0.012 | ||
| TIMP3 | TIMP metallopeptidase inhibitor 3 | 0.012 | ||
| STAT3 | signal transducer and activator of transcription 3 (acute-phase response factor) | 0.012 | ||
| SHC1 | SHC (Src homology 2 domain containing) transforming protein 1 | 0.012 | ||
| ACACA | acetyl-CoA carboxylase alpha | 0.012 | ||
| PTGIS | prostaglandin I2 (prostacyclin) synthase | 0.011 | ||
| PABPC1 | poly(A) binding protein, cytoplasmic 1 | 0.011 | ||
| KAT2B | K(lysine) acetyltransferase 2B | 0.011 | ||
| NCOR1 | nuclear receptor corepressor 1 | 0.011 | ||
| FOXC1 | forkhead box C1 | 0.011 | Human Mouse | |
| TAF12 | TAF12 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 20kDa | 0.011 | ||
| FTSJ3 | FtsJ homolog 3 (E. coli) | 0.011 | ||
| TRIM9 | tripartite motif containing 9 | 0.011 | ||
| EPAS1 | endothelial PAS domain protein 1 | 0.010 | ||
| FST | follistatin | 0.010 | Mouse | |
| DVL3 | dishevelled, dsh homolog 3 (Drosophila) | 0.010 | Fly | |
| NDP | Norrie disease (pseudoglioma) | 0.010 | ||
| SSTR3 | somatostatin receptor 3 | 0.010 |